Novartis receives FDA approval of Xolair® (omalizumab) self-injection with prefilled syringe across all indications for appropriate patients
Source URL: https://qa1.novartis.us/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/novartis-receives-fda-approval-xolair-omalizumab-self-injection-prefilled-syringe-across-all-indications-appropriate-patients-0